| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.4M | -0.1% | -77.3% |
| SG&A Expense | $2.8M | +16.0% | -47.8% |
| Pre-tax Income | -$3.6M | +27.0% | +74.9% |
| Income Tax | $0 | — | — |
| Net Income | -$3.6M | +27.0% | +74.9% |
| EPS (Basic) | -$0.61 | +95.5% | +98.5% |
| EPS (Diluted) | -$0.61 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $269.7M | — | — |
| Short-term Investments | $44.7M | — | — |
| Current Assets | $316.4M | — | — |
| Total Assets | $320.7M | — | — |
| Current Liabilities | $6.6M | — | — |
| Total Liabilities | $10.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.1M | — | — |
| Capital Expenditures | $12K | — | — |
| Investing Cash Flow | -$39.8M | — | — |
| Financing Cash Flow | $303.7M | — | — |
| Free Cash Flow | -$17.1M | — | — |
| +98.5% |
| — |
| Stockholders' Equity | $310.2M | +398.7% | +439.2% |